查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1265837

临床试验前受託研究机构的全球市场

Preclinical Contract Research Organizations
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 89 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

临床试验前受託研究机构的全球市场在2030年前将达到102亿美元

在COVID-19后改变的商务环境中，2022年57亿美元的临床试验前受託研究机构的全球市场，在2030年前将达到102亿美元的规模，在2022年～2030年预计将以年复合成长率7.5％增长。本报告所分析之市场区隔之一的毒物检验年复合成长率将记录8％，到分析期间结束时将达到29亿美元。考虑疫情后的復苏趋势，生物分析&DMPK研究领域今后8年的年复合成长率将修正为被再调整8.4％。

美国市场估算为17亿美元，中国则将以年复合成长率7％成长

美国的临床试验前受託研究机构市场在2022年估算为17亿美元。作为世界第2大经济大国的中国，在2022年～2030年预计将以年复合成长率7％推移，在2030年前将达到18亿美元的市场规模。其他热门的地区市场有日本和加拿大，从2022年到2030年将各以6.8％和5.5％的速度成长。在欧洲市场中，德国以年复合成长率5.7％成长。

调查对像企业范例

  • Envigo Corporation
  • Eurofins Scientific
  • ICON Plc
  • Laboratory Corporation of America, Inc.
  • Medpace, Inc.
  • MPI research
  • PARAXEL International Corporation
  • Pharmaceutical Product Development(PPD), LLC
  • PRA Health Sciences, Inc.
  • Wuxi AppTec

目录

第1章 调查手法

第2章 摘要整理

  • 市场概要
  • 主要企业
  • 市场趋势与推动因素
  • 全球市场预测

第3章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲
  • 亚太地区
  • 全球其他地区

第4章 竞争

简介目录
Product Code: MCP22616

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Preclinical Contract Research Organizations Market to Reach $10.2 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Preclinical Contract Research Organizations estimated at US$5.7 Billion in the year 2022, is projected to reach a revised size of US$10.2 Billion by 2030, growing at aCAGR of 7.5% over the period 2022-2030. Toxicology Testing, one of the segments analyzed in the report, is projected to record 8% CAGR and reach US$2.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Bioanalysis & DMPK Studies segment is readjusted to a revised 8.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.7 Billion, While China is Forecast to Grow at 7% CAGR

The Preclinical Contract Research Organizations market in the U.S. is estimated at US$1.7 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2030 trailing a CAGR of 7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.8% and 5.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.

Select Competitors (Total 33 Featured) -

  • Envigo Corporation
  • Eurofins Scientific
  • ICON Plc
  • Laboratory Corporation of America, Inc.
  • Medpace, Inc.
  • MPI research
  • PARAXEL International Corporation
  • Pharmaceutical Product Development (PPD), LLC
  • PRA Health Sciences, Inc.
  • Wuxi AppTec

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Preclinical Contract Research Organizations - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Preclinical Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Preclinical Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Bioanalysis & DMPK Studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Bioanalysis & DMPK Studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Bioanalysis & DMPK Studies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Biopharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Government & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Government & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Government & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Medical Device Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 22: World Preclinical Contract Research Organizations Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Compound Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Compound Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 25: World 16-Year Perspective for Compound Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 28: World 16-Year Perspective for Chemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Safety Pharmacology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Safety Pharmacology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 31: World 16-Year Perspective for Safety Pharmacology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Preclinical Contract Research Organizations Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Preclinical Contract Research Organizations by Service - Percentage Breakdown of Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services for the Years 2014, 2023 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Preclinical Contract Research Organizations by End-Use - Percentage Breakdown of Value Sales for Biopharma Companies, Government & Academic Institutes and Medical Device Companies for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Preclinical Contract Research Organizations by Service - Percentage Breakdown of Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services for the Years 2014, 2023 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Preclinical Contract Research Organizations by End-Use - Percentage Breakdown of Value Sales for Biopharma Companies, Government & Academic Institutes and Medical Device Companies for the Years 2014, 2023 & 2030
  • JAPAN
    • Preclinical Contract Research Organizations Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Preclinical Contract Research Organizations by Service - Percentage Breakdown of Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services for the Years 2014, 2023 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Preclinical Contract Research Organizations by End-Use - Percentage Breakdown of Value Sales for Biopharma Companies, Government & Academic Institutes and Medical Device Companies for the Years 2014, 2023 & 2030
  • CHINA
    • Preclinical Contract Research Organizations Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: China 16-Year Perspective for Preclinical Contract Research Organizations by Service - Percentage Breakdown of Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services for the Years 2014, 2023 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: China 16-Year Perspective for Preclinical Contract Research Organizations by End-Use - Percentage Breakdown of Value Sales for Biopharma Companies, Government & Academic Institutes and Medical Device Companies for the Years 2014, 2023 & 2030
  • EUROPE
    • Preclinical Contract Research Organizations Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Preclinical Contract Research Organizations by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Preclinical Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Preclinical Contract Research Organizations by Service - Percentage Breakdown of Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services for the Years 2014, 2023 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Preclinical Contract Research Organizations by End-Use - Percentage Breakdown of Value Sales for Biopharma Companies, Government & Academic Institutes and Medical Device Companies for the Years 2014, 2023 & 2030
  • FRANCE
    • Preclinical Contract Research Organizations Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: France 16-Year Perspective for Preclinical Contract Research Organizations by Service - Percentage Breakdown of Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services for the Years 2014, 2023 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: France 16-Year Perspective for Preclinical Contract Research Organizations by End-Use - Percentage Breakdown of Value Sales for Biopharma Companies, Government & Academic Institutes and Medical Device Companies for the Years 2014, 2023 & 2030
  • GERMANY
    • Preclinical Contract Research Organizations Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Preclinical Contract Research Organizations by Service - Percentage Breakdown of Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services for the Years 2014, 2023 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Preclinical Contract Research Organizations by End-Use - Percentage Breakdown of Value Sales for Biopharma Companies, Government & Academic Institutes and Medical Device Companies for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Preclinical Contract Research Organizations by Service - Percentage Breakdown of Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services for the Years 2014, 2023 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Preclinical Contract Research Organizations by End-Use - Percentage Breakdown of Value Sales for Biopharma Companies, Government & Academic Institutes and Medical Device Companies for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Preclinical Contract Research Organizations Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Preclinical Contract Research Organizations by Service - Percentage Breakdown of Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services for the Years 2014, 2023 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Preclinical Contract Research Organizations by End-Use - Percentage Breakdown of Value Sales for Biopharma Companies, Government & Academic Institutes and Medical Device Companies for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Preclinical Contract Research Organizations by Service - Percentage Breakdown of Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services for the Years 2014, 2023 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Preclinical Contract Research Organizations by End-Use - Percentage Breakdown of Value Sales for Biopharma Companies, Government & Academic Institutes and Medical Device Companies for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Preclinical Contract Research Organizations Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Preclinical Contract Research Organizations by Service - Percentage Breakdown of Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services for the Years 2014, 2023 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Preclinical Contract Research Organizations by End-Use - Percentage Breakdown of Value Sales for Biopharma Companies, Government & Academic Institutes and Medical Device Companies for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Preclinical Contract Research Organizations by Service - Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 103: Rest of World 16-Year Perspective for Preclinical Contract Research Organizations by Service - Percentage Breakdown of Value Sales for Toxicology Testing, Bioanalysis & DMPK Studies, Compound Management, Chemistry, Safety Pharmacology and Other Services for the Years 2014, 2023 & 2030
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for Preclinical Contract Research Organizations by End-Use - Biopharma Companies, Government & Academic Institutes and Medical Device Companies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 106: Rest of World 16-Year Perspective for Preclinical Contract Research Organizations by End-Use - Percentage Breakdown of Value Sales for Biopharma Companies, Government & Academic Institutes and Medical Device Companies for the Years 2014, 2023 & 2030

IV. COMPETITION